While AKR1B10 promotes tumorigenesis in HCC, breast cancer, lung cancer, and pancreatic cancer (41, 48–50), we demonstrate that its expression predicts better prognosis in gastrointestinal cancers, based on analyses of public databases and patient samples from FAH-SYSU. Here, AKR1B10 is linked to familial pancreatic carcinoma.